Catégorie
Irinotecan
Numéro CAS
100286-90-6
Autre numéro CAS
Irinotecan Hydrochloride Trihydrate - 136572-09-3 , Free base - 97682-44-5
Formule moléculaire
C33H39ClN4O6
Masse moléculaire
623.15 g/mol
Synonyme

 (S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate Hydrochloride ;

Mots-clés
Chiral standards
Enzyme inhibitors
Pharmaceutical Standards
Intermediates
Fine Chemicals
slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Irinotecan hydrochloride is used as a chemotherapy agent for treating colorectal cancer and other solid tumors by inhibiting topoisomerase I and blocking cancer cell DNA replication. It is typically administered intravenously, either alone or in combination regimens such as FOLFIRI, to improve therapeutic effectiveness and patient outcomes.